KR830000680A - N-알킬화 아미노알콜의 제조방법 - Google Patents

N-알킬화 아미노알콜의 제조방법 Download PDF

Info

Publication number
KR830000680A
KR830000680A KR1019820001067A KR820001067A KR830000680A KR 830000680 A KR830000680 A KR 830000680A KR 1019820001067 A KR1019820001067 A KR 1019820001067A KR 820001067 A KR820001067 A KR 820001067A KR 830000680 A KR830000680 A KR 830000680A
Authority
KR
South Korea
Prior art keywords
group
alk
general formula
substituted
producing
Prior art date
Application number
KR1019820001067A
Other languages
English (en)
Inventor
오스터마이어 푸란쯔
찌머만 다르쿠스
Original Assignee
아놀드 자인러 에른스트 알테르
시바 가이기 에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아놀드 자인러 에른스트 알테르, 시바 가이기 에이지 filed Critical 아놀드 자인러 에른스트 알테르
Publication of KR830000680A publication Critical patent/KR830000680A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

내용 없음

Description

N-알킬화 아미노알콜의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 일반식(V)의 화합물을 수소화시킴을 특징으로 하는 일반식(I)의 N-알킬화 아미노알콜 및 그의 염을 제조하는 방법.
    상기식에서
    Ar은 치환되지 않거나 하이드록실로 치환된 방향족기이고,
    n은 0 또는 1이며,
    Alk는 탄소수 2 내지 5개의 알킬렌기이며,
    질소원자는 산소원자 또는 n이 0인 경우에는 페닐기와 적어도 2개의 탄소원자에 의해 서로 분리되어 있고,
    X6는 일반식 -CH=N-Alk-(Va), -CH2-N=Alk1, (Vb), -C(=X7)-N(X8)-Alk-(Vc), -CH2-N(X8)-C(=X7)-Alk2-(Vd) 또는 -CH2-N(X8)-Alk-(Ve)의 환원성 그룹이며,
    Alk1은 Alk기에 상응하는 알킬-일리덴기이고,
    Alk2는 질소원자에 결합된 메틸렌기에 의해 단축된(즉 탄소수가 1개 적은) Alk기에 상응하는 기,
    X7은 옥소와 티오옥소기,
    X8은 수소 또는 X6및/또는 Y를 환원시키는 조건하에서 수소로 치환될 수 있는 기이고,
    Y는 일반식 -CO-(Vf) 또는 -CH(OX8)-(Vg)기 (이때 X8은 전술된 바와 같음)이고,
    Ar2는 Ar기에 상응하지만 한개나 두개의 하이드록실기 대신에 한개나 두개의 OX8그룹(이때 X8은 전술된 바와 같음)을 수반할 수 있다.
    ※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
KR1019820001067A 1978-06-05 1982-03-12 N-알킬화 아미노알콜의 제조방법 KR830000680A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH613678 1978-06-05
CH6136/78-4? 1978-06-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR7901814A Division KR840000926B1 (ko) 1978-06-05 1979-06-04 N-알킬화된 아미노알콜의 제조방법

Publications (1)

Publication Number Publication Date
KR830000680A true KR830000680A (ko) 1983-04-18

Family

ID=4304840

Family Applications (4)

Application Number Title Priority Date Filing Date
KR7901814A KR840000926B1 (ko) 1978-06-05 1979-06-04 N-알킬화된 아미노알콜의 제조방법
KR1019820001066A KR830000679A (ko) 1978-06-05 1982-03-12 N-알킬화 아미노알콜의 제조방법
KR1019820001067A KR830000680A (ko) 1978-06-05 1982-03-12 N-알킬화 아미노알콜의 제조방법
KR1019820001068A KR830000681A (ko) 1978-06-05 1982-03-12 N-알킬화 아미노알콜의 제조방법

Family Applications Before (2)

Application Number Title Priority Date Filing Date
KR7901814A KR840000926B1 (ko) 1978-06-05 1979-06-04 N-알킬화된 아미노알콜의 제조방법
KR1019820001066A KR830000679A (ko) 1978-06-05 1982-03-12 N-알킬화 아미노알콜의 제조방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019820001068A KR830000681A (ko) 1978-06-05 1982-03-12 N-알킬화 아미노알콜의 제조방법

Country Status (26)

Country Link
US (1) US4460580A (ko)
EP (1) EP0005848B1 (ko)
JP (1) JPS54163543A (ko)
KR (4) KR840000926B1 (ko)
AR (3) AR229581A1 (ko)
AT (1) ATE511T1 (ko)
AU (1) AU522483B2 (ko)
CA (1) CA1124241A (ko)
CY (1) CY1256A (ko)
DD (1) DD144050A5 (ko)
DE (1) DE2961669D1 (ko)
DK (1) DK229879A (ko)
ES (1) ES481238A1 (ko)
FI (1) FI791727A (ko)
GB (1) GB2026474B (ko)
GR (1) GR74057B (ko)
HK (1) HK15585A (ko)
HU (1) HU182019B (ko)
IL (1) IL57471A (ko)
MY (1) MY8500690A (ko)
NO (1) NO149034C (ko)
NZ (1) NZ190632A (ko)
PL (5) PL116529B1 (ko)
PT (1) PT69723A (ko)
SG (1) SG45884G (ko)
ZA (1) ZA792748B (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100380520B1 (ko) * 2000-09-08 2003-04-23 한국화학연구원 피리딘을 포함한 β-아미노알코올 유도체
CN104008939A (zh) * 2014-06-19 2014-08-27 苏州普京真空技术有限公司 一种耐用电子枪灯丝

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
ZA803879B (en) 1979-06-29 1981-06-24 Glaxo Group Ltd Heterocyclic compounds, processes for their preparation and their use
DD202692A5 (de) * 1979-12-04 1983-09-28 Ciba Geigy Verfahren zur herstellung neuer derivate des 2-amino-aethanols
JPS5726653A (en) * 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
GR74992B (ko) * 1980-08-13 1984-07-12 Ciba Geigy Ag
JPS57185243A (en) * 1981-05-08 1982-11-15 Ciba Geigy Ag Substituted 2-aminoethanol
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
FR2543139B1 (fr) * 1983-03-22 1985-08-16 Cerm Cent Europ Rech Mauvernay Derives de (1-alcoxy 2-amino) ethyl pyridine ou pyrazine, leur preparation et leur application en therapeutique
DE3608290A1 (de) * 1986-03-13 1987-09-24 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1287061C (en) * 1986-06-27 1991-07-30 Roche Holding Ltd. Pyridine ethanolamine derivatives
GB8714901D0 (en) * 1986-07-23 1987-07-29 Ici Plc Amide derivatives
DE3627663A1 (de) * 1986-08-14 1988-03-03 Bayer Ag Heteroarylethylamine, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer bei tieren
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
JPH0466934A (ja) * 1990-07-04 1992-03-03 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
ATE313321T1 (de) * 1991-08-23 2006-01-15 Nps Pharma Inc Kalzium-rezeptor aktive verbindungen
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5208252A (en) * 1992-07-24 1993-05-04 Ortho Pharmaceutical Corporation Aminoethylthiophene derivatives
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
AU1533495A (en) * 1994-01-12 1995-08-01 Byk Nederland Bv Phenyl ethanol amine ethers and uses thereof as beta-adreno-receptor agonists
RU2195446C2 (ru) 1994-12-08 2002-12-27 Эн-Пи-Эс Фармасьютикалз, Инк. Соединения, обладающие активностью в отношении рецептора кальция (варианты), фармацевтическая композиция и способы лечения (варианты)
WO1997041090A1 (en) 1996-05-01 1997-11-06 Nps Pharmaceuticals, Inc. Inorganic ion receptor-active compounds
EP1500126A1 (en) * 2002-04-22 2005-01-26 Koninklijke Philips Electronics N.V. Luminescent screen
US7538141B2 (en) * 2004-03-23 2009-05-26 Alan Daniel Brown Compounds for the treatment of diseases
WO2011112243A2 (en) * 2010-03-08 2011-09-15 The University Of Tennessee Research Foundation Beta -adrenergic receptor agonists and uses thereof
ITMI20122221A1 (it) * 2012-12-21 2014-06-22 C4T S C A R L Nuovi composti del 2,3-diidro-4h-1,3-benzossazin-4-one, metodo per prepararli e forma farmaceutica che li comprende

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1178400A (en) * 1966-12-13 1970-01-21 Delalande Sa Nitrogen Substituted Amines and their process of Preparation.
DE1543538A1 (de) * 1966-12-30 1976-02-05 Degussa Verfahren zur herstellung neuer heterocyclischer aminoalkohole
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
US4082772A (en) * 1975-04-18 1978-04-04 American Home Products Corporation Thiophene ethanolamines
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100380520B1 (ko) * 2000-09-08 2003-04-23 한국화학연구원 피리딘을 포함한 β-아미노알코올 유도체
CN104008939A (zh) * 2014-06-19 2014-08-27 苏州普京真空技术有限公司 一种耐用电子枪灯丝
CN104008939B (zh) * 2014-06-19 2016-05-11 苏州普京真空技术有限公司 一种耐用电子枪灯丝

Also Published As

Publication number Publication date
KR830000679A (ko) 1983-04-18
HU182019B (en) 1983-12-28
PL117155B1 (en) 1981-07-31
PL117158B1 (en) 1981-07-31
PL116529B1 (en) 1981-06-30
IL57471A (en) 1982-11-30
AU4773679A (en) 1979-12-13
DD144050A5 (de) 1980-09-24
FI791727A (fi) 1979-12-06
NO149034C (no) 1984-02-01
CA1124241A (en) 1982-05-25
JPS54163543A (en) 1979-12-26
MY8500690A (en) 1985-12-31
DE2961669D1 (en) 1982-02-18
AU522483B2 (en) 1982-06-10
NO149034B (no) 1983-10-24
KR830000681A (ko) 1983-04-18
AR229951A1 (es) 1984-01-31
CY1256A (en) 1984-11-23
PL216090A1 (ko) 1980-03-24
SG45884G (en) 1985-03-08
ZA792748B (en) 1980-06-25
GB2026474A (en) 1980-02-06
HK15585A (en) 1985-03-15
NO791841L (no) 1979-12-06
EP0005848B1 (de) 1981-12-30
DK229879A (da) 1979-12-06
ES481238A1 (es) 1980-02-16
NZ190632A (en) 1984-07-06
KR840000926B1 (ko) 1984-06-29
GR74057B (ko) 1984-06-06
EP0005848A1 (de) 1979-12-12
US4460580A (en) 1984-07-17
AR229581A1 (es) 1983-09-30
ATE511T1 (de) 1982-01-15
PL116612B1 (en) 1981-06-30
PL116597B1 (en) 1981-06-30
GB2026474B (en) 1982-07-14
PT69723A (de) 1979-07-01
AR229022A1 (es) 1983-05-31

Similar Documents

Publication Publication Date Title
KR830000680A (ko) N-알킬화 아미노알콜의 제조방법
SE8303910D0 (sv) 15-deoxi-hydroxiprostaglandiner och forfarande for framstellning derav
KR840000483A (ko) 유기화합물의 개량
KR840005084A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
KR900009935A (ko) 액정 조성물
KR890002198A (ko) 유기 규소 화합물
KR830007503A (ko) 신규트리아민유도체의 제조방법 및 이 유도체를 함유하는 수지조성물
KR900004820A (ko) 안정화된 합성수지조성물
KR860700250A (ko) 신규 아미딘 화합물
KR840006486A (ko) 벤조디옥시노피롤 유도체의 제조방법
KR880008980A (ko) 안트라퀴논 화합물 및 이를 함유하는 편광 필름
KR830007626A (ko) 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법
KR870007894A (ko) 신규이미다졸 화합물의 제조방법
KR890012991A (ko) 광학활성을 갖는 4-옥소-1-벤조피란-2-카르복시산 유도체 및 중간체의 제법
KR860003201A (ko) 톨루엔디아민 조성물
KR920702685A (ko) 4,6-o- 히드록시포스포릴글루코사민 유도체
KR910018372A (ko) 에테르 결합을 갖는 페닐시클로헥실디옥산 유도체
KR830005122A (ko) 1-아릴옥시-3-알킬아미노-2-프로판올류의 제조방법
KR850001742A (ko) 큐말산 에스테르의 제조방법
KR920006410A (ko) 열안정성 폴리아미드수지의 제조방법
KR870007986A (ko) 오르가노폴리실록산 경화물의 제조방법
KR920009792A (ko) 3-아미노-4-메틸렌피롤리딘 유도체의 제조방법
KR890005096A (ko) 빈카민산 유도체
KR870006836A (ko) 브라시노 라이드 유사체의 제조방법
KR830006266A (ko) 카바메이트유도체의 제조방법